Cargando…
Oral administration of D-glucosamine confers broad-spectrum protection against human coronaviruses including SARS-CoV-2
Autores principales: | Qi, Qi, Chen, Qi, Dong, Yumei, Wang, Kun, Wang, Jialu, Jin, Guiming, Zheng, Aiping, Zhang, Rong, Deng, Yongqiang, Li, Yuhuan, Qin, Chengfeng, Duan, Xiaotao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262929/ https://www.ncbi.nlm.nih.gov/pubmed/37311738 http://dx.doi.org/10.1038/s41392-023-01483-8 |
Ejemplares similares
-
Naphthoquine: A Potent Broad-Spectrum Anti-Coronavirus Drug In Vitro
por: Song, Yabin, et al.
Publicado: (2022) -
ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker
por: Chen, Yuning, et al.
Publicado: (2021) -
An mRNA-based broad-spectrum vaccine candidate confers cross-protection against heterosubtypic influenza A viruses
por: Xiong, Feifei, et al.
Publicado: (2023) -
ty-5 Confers Broad-Spectrum Resistance to Geminiviruses
por: Ren, Yanxiang, et al.
Publicado: (2022) -
Conserved coronavirus proteins as targets of broad-spectrum antivirals
por: Melo-Filho, Cleber C., et al.
Publicado: (2022)